Table 1.
Clinical characteristic of patients with STEMI according to glucometabolic classifications by an OGTT in-hospital and after three months
| In-hospital | At three-month follow-up | |||||
|---|---|---|---|---|---|---|
| NGR (n = 119) | AGR (n = 105) | P | NGR (n = 151) | AGR (n = 50) | P | |
| Age (years) | 55 (50,63) | 60 (54,71) | <0.001 | 57 (51, 65) | 61 (52, 72) | 0.04 |
| Men | 106 (89.1) | 79 (75.2) | <0.01 | 129 (85.4) | 36 (72.0) | 0.03 |
| Previous disorders | ||||||
| Treated dyslipidaemia | 11 (9.2) | 9 (8.6) | 0.86 | 15 (9.9) | 4 (8.0) | 0.47 |
| Treated hypertension | 25 (21) | 33 (31.4) | 0.32 | 38 (25.2) | 17 (34.0) | 0.23 |
| Previous acute MI | 9 (7.6) | 7 (6.7) | 0.08 | 10 (6.6) | 4 (8.0) | 0.48 |
| Previous angina pectoris | 5 (4.2) | 2 (1.9) | 0.33 | 6 (4.0) | 1 (2.0) | 0.45 |
| Current smoker | 65 (54.6) | 44 (41.9) | 0.06 | 67 (44.4) | 24 (48.0) | 0.66 |
| Body mass index (kg/m2) | 25.9 (24.5, 28.7) | 26.1 (24.3, 28.6) | 0.82 | 26.1 (24.4, 28.5) | 25.7 (24.1, 28.7) | 0.73 |
| Waist circumference | 100 (94, 107) | 99 (94, 107) | 0.86 | 101 (94, 107) | 98 (94, 107) | 0.92 |
| Cholesterol (mmo/L) | 5.2 (4.5, 5.8) | 5.1 (4.4, 5.8) | 0.52 | 4.1 (3.8, 4.6) | 4.0 (3.6, 4.8) | 0.43 |
| LDL-cholesterol (mmol/L) | 3.4 (2.7, 4.2) | 3.3 (2.7, 4.0) | 0.54 | 2.2 (1.8, 2.6) | 2.1 (1.7, 2.6) | 0.42 |
| Triglycerides (mmo/L) | 1.4 (1.0,1.8) | 1.2 (0.9,1.8) | 0.11 | 1.2 (0.9, 1.6) | 1.2 (1.1, 1.6) | 0.64 |
| Stents | 114 (95.8) | 101 (96.2) | 0.88 | 143 (94.7) | 49 (98.0) | 0.30 |
| One-vessel disease | 78 (65.5) | 61 (58.1) | 0.25 | 92 (60.9) | 30 (60.0) | 0.91 |
| Left main disease | 47 (39.5) | 42 (40.0) | 0.94 | 58 (38.4) | 21 (42.0) | 0.65 |
| IIb/IIIa inhibitors | 37 (31.1) | 42 (40.0) | 0.17 | 54 (35.8) | 19 (38.0) | 0.78 |
| TnT peak value (ug/L) | 4.47 (2.39, 7.32) | 5.63 (2.78,10.89) | 0.03 | 4.85 (2.45, 8.31) | 4.97 (2.38, 10.25) | 0.47 |
| Measured at three-month. | ||||||
| LVEF1 (%) | 64 (57, 70) | 62 (52,69) | 0.13 | 63.5 (56, 70) | 63.5 (51, 69) | 0.47 |
| Infarct size2 (%) | 9 (0, 25) | 20 (4.5, 32) | <0.001 | 13 (0, 27) | 21.5 (0, 43) | 0.04 |
| Medication at discharge from CCU and after three months. | ||||||
| Aspirin | 119 (100) | 105 (100) | 150 (99.3) | 50 (100) | 0.57 | |
| Clopidogrel | 118 (99.2) | 104 (99.0) | 0.93 | 143 (94.7) | 46 (92.0) | 0.49 |
| β-blockers | 96 (80.7) | 85 (81.0) | 0.96 | 142 (94.0) | 46 (92.0) | 0.61 |
| Lipid lowering agents | 118 (99.2) | 103 (99.1) | 0.49 | 146 (96.7) | 48 (96.0) | 0.82 |
| ACEIs | 19 (16) | 17 (16.2) | 0.96 | 52 (34.4) | 17 (34.0) | 0.96 |
| ARBs | 8 (6.7) | 10 (9.5) | 0.44 | 21 (13.9) | 4 (8.0) | 0.27 |
Data are presented as median values (25, 75 percentiles) or proportions.
ACEIs: angiotensin-converting enzyme inhibitors, AGR: abnormal glucose regulation, acute MI: acute myocardial infarction, ARBs: angiotensin receptor blockers, CCU: coronary care unit, NGR: normal glucose regulation, TnT peak level: serum peak level of cardiac specific Troponin T. 1,2Measured at three months by SPECT analysis, 1LVEF: left ventricular ejection fraction, 2infarct size in % of left ventricular mass.